ICOTF Financials 07/16/2014 03:58:55 Ico Therapeu

ICOTF Financials 07/16/2014 03:58:55
Ico Therapeutics, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 3,836 2,297 1,106 1,782
Sales, General and Admin. 1,940 1,381 1,323 1,445
Non-Recurring Items - - - -
Other - - - -
Operating Income (5,776) (3,678) (2,430) (3,227)
Income From Continuing Operations
Add'l Income/Expense Items 441 19 1,416 102
Earnings Before Interest and Tax (5,335) (3,658) (1,014) (3,124)
Interest Expense - - - -
Earnings Before Tax (5,335) (3,658) (1,014) (3,124)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (5,335) (3,658) (1,014) (3,124)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (5,335) (3,658) (1,014) (3,124)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (5,335) (3,658) (1,014) (3,124)